Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 April 2021 | Story Dr Nitha Ramnath | Photo Supplied
Dr Johan Coetzee, Senior Lecturer and researcher in the Department of Economics and Finance and the UFS Business School

Dr Johan Coetzee from the Faculty of Economic and Management Sciences at the University of the Free State (UFS) is championing a collaboration with the Salzburg University of Applied Sciences (SUAS) in Austria, resulting in the receipt of a considerable grant from the European Union. 

In 2020, the decision was made to apply for Erasmus+ funding from the European Commission; after a successful grant, a formal inter-institutional agreement was signed in March 2021. The agreement is the culmination of a relationship between the Department of Economics and Finance at the UFS and the Department of Controlling and Finance at SUAS since 2008. More specifically, the relationship is built on the collaboration between the UFS’s Dr Coetzee and Prof Christine Mitter from the SUAS, who was recently appointed as a Research Fellow in Finance in the department. 

“I am extremely proud of the formalisation of the relationship between the two universities. In late 2019, a delegation led by the Dean of Economic and Management Sciences, Prof Hendri Kroukamp, together with Prof Philippe Burger and myself visited Salzburg to formalise and iron out the expectations regarding future collaboration,” says Dr Coetzee. 

“The Erasmus+ grant pays testament to not only on-boarding expertise from a foreign university with a strong niche in being practically relevant to the Austrian society, but also to affirming the relationship with like-minded scholars to provide students with a culturally rewarding university experience. This agreement brings together two departments with a history of working well together, and now it is a formal manifestation of years of mutually beneficial teaching and research efforts,” says Dr Coetzee.

“On the back of this agreement,” concludes Dr Coetzee, “our departments are also currently finalising a proposal to offer a consecutive degree exchange programme where prospective postgraduate students will obtain two master’s degrees in the broader field of finance and spend time on both campuses. We look forward to this becoming a reality in the not-too-distant future.”

In addition to their teaching and research collaboration, several additional academics from the Department of Economics and Finance are also involved in the teaching collaboration. Research projects have also been concluded in the past, with future projects in the pipeline.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept